The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
IKANG HEALTHCARE GROUP-ADR | ADR | 45174L108 | 604 | 41,356 | SH | SOLE | none | 41,356 | 0 | 0 | |
MEAD JOHNSON NUTRITION CO | COM | 582839106 | 211,115 | 2,369,948 | SH | SOLE | none | 2,344,781 | 0 | 25,167 | |
REYNOLDS AMERICAN INC | COM | 761713106 | 302,194 | 4,795,181 | SH | SOLE | none | 4,767,867 | 0 | 27,314 | |
SCICLONE PHARMACEUTICALS INC | COM | 80862K104 | 3,979 | 405,985 | SH | SOLE | none | 405,985 | 0 | 0 | |
SYNUTRA INTERNATIONAL INC | COM | 87164C102 | 7,326 | 1,231,192 | SH | SOLE | none | 1,231,192 | 0 | 0 |